About
ARKG was created on 2014-10-31 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 1051.63m in AUM and 34 holdings. ARKG is an actively managed fund that targets companies involved in the genomics industry.
Current Value
$19.011 Year Return
Current Value
$19.011 Year Return
Key Details
Assets Under Management
$987.53M
Div Yield %
-
P/E Ratio
-
Net Asset Value
$19.72
Expense Ratio
0.75%
1Y ETF Return
-0.26%
Holdings
ARKG - ARK Genomic Revolution ETF contains 34 holdings. The top holdings include TWST, TEM, CRSP, RXRX, GH
Name | Weight |
|---|---|
9.01% | |
8.14% | |
7.78% | |
6.46% | |
6.33% | |
6.13% | |
 NTRANatera, Inc. | 6.12% |
4.7% | |
 CDNACareDx, Inc. | 4.52% |
 VCYTVeracyte, Inc. | 3.94% |
3.65% | |
3.16% | |
 ABSIAbsci Corp. | 2.52% |
2.52% | |
 PSNLPersonalis, Inc. | 2.47% |
2.43% | |
2.05% | |
 AMGNAmgen, Inc. | 2.05% |
1.78% | |
1.59% | |
1.55% | |
1.46% | |
1.33% | |
 ILMNIllumina, Inc. | 1.26% |
1.18% | |
 INCYIncyte Corp. | 1.17% |
 CERSCerus Corp. | 1.08% |
1.05% | |
0.94% | |
0.55% | |
Sector | Weight |
|---|---|
Health Care | 98.68% |
Information Technology | 1.18% |
Stock's related to ARKG
The stocks that are correlated to ARKG - ARK Genomic Revolution ETF are RXRX, CRSP, BEAM, TWST, NTLA
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| 79.43% | $1.93B | -44.90% | 0.00% | |
| 77.99% | $2.80B | -49.80% | 0.00% | |
| 75.77% | $1.64B | -43.30% | 0.00% | |
| 70.15% | $2.24B | +17.26% | 0.00% | |
| 69.41% | $713.23M | -72.41% | 0.00% | |
| 68.04% | $1.38B | -27.56% | 0.00% | |
| 67.90% | $622.79M | -52.50% | 0.00% | |
| 66.23% | $1.10B | +171.43% | 0.00% | |
| VCYTVeracyte, Inc. | 63.61% | $2.22B | +41.15% | 0.00% |
| 63.53% | $974.75M | -77.70% | 0.00% | |
| 63.36% | $3.16B | -13.91% | 0.50% | |
| 63.30% | $1.86B | -32.65% | 0.00% | |
| 61.80% | $354.44M | -64.26% | 0.00% | |
| 61.24% | $697.83M | -65.05% | 0.00% | |
| 61.22% | $1.18B | -15.60% | 0.00% | |
| 59.51% | $73.01M | -82.71% | 0.00% | |
| 59.44% | $11.67B | +45.55% | 0.00% | |
| 59.27% | $5.70B | -18.63% | 0.00% | |
| 59.26% | $75.46B | +25.56% | 0.69% | |
| 58.92% | $10.14B | +25.87% | 0.00% | |
ETF's related to ARKG
The ETFs that are correlated to ARKG - ARK Genomic Revolution ETF are GNOM, XBI, CPRJ, ARKK, KOMP
News
SeekingAlpha
In this episode of the MoneyShow MoneyMasters Podcast, we break down what tariffs could mean for the markets and your portfolio.
SeekingAlpha
U.S. Federal government debt has reached the level where interest payments are now the largest single line item.
SeekingAlpha
The day of reckoning for tariffs is rapidly approaching, and we're anticipating substantial disruption for the pharmaceutical sector. Read more here.
SeekingAlpha
Uncertainty around U.S. government policy â particularly tariffs â is resulting in elevated levels of market volatility, with some names down as much as -50%.
SeekingAlpha
How ESG Policies Can Keep The Healthcare Sector Fighting Fit
SeekingAlpha
Outside of computers and peripherals, one sees little evidence of tariff avoidance in capital goods imports.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
0% Expense Ratios with TLH
We offer over 50 indexes with zero expense ratios.
Registration will take about 10 seconds